z-logo
Premium
Lifestyle changes and clinical profile in coronary heart disease patients with an ejection fraction of ≤40% or >40% in the Multicenter Lifestyle Demonstration Project
Author(s) -
Pischke Claudia R.,
Weidner Gerdi,
ElliottEller Melanie,
Ornish Dean
Publication year - 2007
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2007.05.009
Subject(s) - medicine , ejection fraction , heart failure , cardiology , coronary heart disease , multicenter study , coronary disease , disease , fraction (chemistry) , randomized controlled trial , chemistry , organic chemistry
Background: Lifestyle changes are recommended for coronary heart disease (CHD) patients at risk for heart failure (HF) [ACC/AHA stage B; left ventricular ejection fraction (LVEF)≤40%]. However, it is not clear whether changes in lifestyle are feasible and beneficial in these patients. Aim: To investigate the feasibility of intensive lifestyle changes for CHD patients at risk for HF. Methods: We compared 50 patients (18% female) with angiographically documented LVEF≤40% (mean=33.4±7.3; range: 15–40%) to 186 patients (18% female) with LVEF>40% (mean=58.2±9.6; range: 42–87%), who were participants in the Multicenter Lifestyle Demonstration Project (MLDP). All were non‐smoking CHD patients. The MLDP was a community‐based, insurance‐sponsored intervention (low‐fat, plant‐based diet; exercise; stress management) implemented at 8 sites in the US. Coronary risk factors, lifestyle and quality of life (SF‐36) were assessed at baseline, 3 and 12 months. Results: Regardless of LVEF, patients showed significant improvements (all p <.05) in lifestyle behaviours, body weight, body fat, blood pressure, resting heart rate, total and LDL‐cholesterol, exercise capacity, and quality of life by 3 months; most improvements were maintained over 12 months. Conclusion: CHD patients at risk for heart failure with an LVEF≤40%, can make changes in lifestyle to achieve similar medical and psychosocial benefit to patients with an LVEF>40%.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom